COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents

Journal article

Open access

Peer reviewed

Hubert Blain, Edouard Tuaillon, Lucie Gamon, Amandine Pisoni, Safa Aouinti, Marie‐christine Picot and Jean Bousquet

Clinical and Translational Allergy, Vol.13(3)

03/2023

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1002/clt2.12224View

Published (Version of record) Open

1 Record Views

Title: COVID‐19 after BNT162b2 two‐dose primary series does not improve the efficacy of a booster dose in nursing home residents
Creators - without role: Hubert Blain - Université de Montpellier
Edouard Tuaillon - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Lucie Gamon - Centre Hospitalier Universitaire de Montpellier
Amandine Pisoni - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Safa Aouinti - Centre Hospitalier Universitaire de Montpellier
Marie‐christine Picot - Centre Hospitalier Universitaire de Montpellier
Jean Bousquet
Publication Details: Clinical and Translational Allergy, Vol.13(3)
Identifiers: 9935173209311
Academic Unit: Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
Language: English
Resource Type: Journal article
Local Fields: hal-04098896